Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Unraveling the antiviral activity of plitidepsin by subcellular and morphological analysis.
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern.
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1.
An anti-SARS-CoV-2 metabolite is reduced in diabetes.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Monitoring Natural SARS-CoV-2 Infection in Lions ( Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes